Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lung cancer research is taking on new challenges: knowledge of tumors' molecular diversity is opening new pathways to treatment.

Literature DB >> 25336866

Lung cancer research is taking on new challenges: knowledge of tumors' molecular diversity is opening new pathways to treatment.

Abstract

Lung cancer treatment has undergone significant change in the past decade, leading to remarkable growth in the number and variety of therapeutic options. This shift reflects, in part, a significant refinement in the molecular categorization of lung cancer.

Entities: Disease

Year: 2014 PMID： 25336866 PMCID： PMC4189696

Source DB: PubMed Journal: P T ISSN： 1052-1372

15 in total

1. Screening for lung cancer: moving into a new era.

Authors: Frank C Detterbeck; Michael Unger
Journal: Ann Intern Med Date: 2014-03-04 Impact factor: 25.391

2. Biomarkers to the rescue in a lung nodule epidemic.

Authors: Pierre P Massion
Journal: J Clin Oncol Date: 2014-02-10 Impact factor: 44.544

3. Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer.

Authors: Sebahat Ocak; David B Friedman; Heidi Chen; Jamie A Ausborn; Mohamed Hassanein; Bruno Detry; Birgit Weynand; Frank Aboubakar; Charles Pilette; Yves Sibille; Pierre P Massion
Journal: J Thorac Oncol Date: 2014-03 Impact factor: 15.609

Review 4. New strategies in lung cancer: translating immunotherapy into clinical practice.

Authors: Patrick M Forde; Ronan J Kelly; Julie R Brahmer
Journal: Clin Cancer Res Date: 2014-01-27 Impact factor: 12.531

Review 5. Immunotherapy in the treatment of non-small cell lung cancer.

Authors: Raghav Sundar; Richie Soong; Byoung-Chul Cho; Julie R Brahmer; Ross A Soo
Journal: Lung Cancer Date: 2014-05-14 Impact factor: 5.705

6. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: Virginia A Moyer
Journal: Ann Intern Med Date: 2014-03-04 Impact factor: 25.391

7. Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancer.

Authors: Shakun M Malik; Richard Pazdur; Jeffrey S Abrams; Mark A Socinski; William T Sause; David H Harpole; John J Welch; Edward L Korn; Claudio Dansky Ullmann; Fred R Hirsch
Journal: J Thorac Oncol Date: 2014-10 Impact factor: 15.609

Lung cancer research is taking on new challenges: knowledge of tumors' molecular diversity is opening new pathways to treatment.

1. Screening for lung cancer: moving into a new era.

2. Biomarkers to the rescue in a lung nodule epidemic.

3. Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer.

Review 4. New strategies in lung cancer: translating immunotherapy into clinical practice.

Review 5. Immunotherapy in the treatment of non-small cell lung cancer.

6. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

7. Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancer.

8. Growth Impairment of Small-Cell Cancer by Targeting Pro-Vasopressin with MAG-1 Antibody.

9. Public attitudes about lung cancer: stigma, support, and predictors of support.

10. Comprehensive molecular profiling of lung adenocarcinoma.

Review 1. A narrative review of deep learning applications in lung cancer research: from screening to prognostication.